STIM
NASDAQ
$1.88
Neuronetics Inc (STIM)
Neuronetics, Inc., a commercial-stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company is headquartered in Malvern, Pennsylvania.
Sector:
Healthcare
Industry:
Medical Devices
Strong Buy
Target: $4.50 (+139.36%)
Market Cap
$128M
Revenue 5Y CAGR
+24.82%
Free Cash Flow Yield
-10.02%
Beta (5Y)
1.70
Price Chart
Valuation
Market Cap$128M
P/S0.84
P/B9.29
Profitability
Total Revenue (TTM)$152M
Gross Profit (TTM)$73M
EBITDA-$26M
Profit Margin-31.3%
Operating Margin-26.1%
EPS-$0.54
Financial Health
Debt-to-Equity462.1%
Free Cash Flow Yield-10.02%
Growth & Risk
EPS 5Y CAGR-12.98%
Revenue 5Y CAGR+24.82%
FCF 5Y CAGR-11.72%
Beta (5Y)1.70
Sharpe Ratio-0.15